Epic

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Epigenica

This company develops epigenetic analysis kits and screening tools for researchers in drug discovery, diagnostics, and precision medicine.

GeneCentric

This company develops gene expression-based liquid biopsy platforms and biomarkers to help pharmaceutical and diagnostic firms identify cancer treatment responders.

Oncobit

This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.

Precede Biosciences

The company develops an epigenomic liquid biopsy platform for biopharmaceutical companies and researchers to profile gene expression and disease biology from blood samples.

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.